The store will not work correctly when cookies are disabled.
2-(8-hydroxyquinolin-2-yl)-3-(4-isopropylphenyl)thiazolidin-4-one
ID: ALA4764436
PubChem CID: 162662193
Max Phase: Preclinical
Molecular Formula: C21H20N2O2S
Molecular Weight: 364.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)c1ccc(N2C(=O)CSC2c2ccc3cccc(O)c3n2)cc1
Standard InChI: InChI=1S/C21H20N2O2S/c1-13(2)14-6-9-16(10-7-14)23-19(25)12-26-21(23)17-11-8-15-4-3-5-18(24)20(15)22-17/h3-11,13,21,24H,12H2,1-2H3
Standard InChI Key: RWZUGYJMXZBVTD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
12.2358 -2.4144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2347 -3.2339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9427 -3.6429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9409 -2.0055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6495 -2.4108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6503 -3.2298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3588 -3.6369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0671 -3.2260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0624 -2.4039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3533 -2.0006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9446 -4.4601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7805 -3.6291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8691 -4.4414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6691 -4.6082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0750 -3.8989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5258 -3.2938 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.2657 -4.9881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4868 -4.7370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8820 -5.2854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0548 -6.0850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8378 -6.3332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4393 -5.7832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0044 -5.3535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4504 -6.6350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6719 -6.3865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6245 -7.4334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
8 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
14 23 2 0
20 24 1 0
24 25 1 0
24 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.47 | Molecular Weight (Monoisotopic): 364.1245 | AlogP: 4.84 | #Rotatable Bonds: 3 |
Polar Surface Area: 53.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 4.51 | CX LogD: 4.51 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -0.69 |
References
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |